The Department of Medicine at the Anschutz Medical Campus boasts top medical care for patients, as well as fellowships and endowments. The Grand Rounds Schedule includes all events for divisions under the department.

Education:  MD

Comenius University, Slovakia

Dr. Kabos joined the UCD faculty in July 2009 and is a member of the breast oncology program. He spent four years as a post-doctoral research fellow at Cedars-Sinai Medical Center studying the biology of normal and cancer stem cells in gliomas. He completed his Internal Medicine residency training at USC Keck School of Medicine in Los Angeles and fellowship in Hematology/Oncology at the University of Colorado Denver.

Research

Dr. Kabos’ interest is in translating preclinical findings into novel treatments for patients with breast cancer. The Kabos lab focuses on the role of breast cancer stem cells and tumor microenvironment in treatment resistance.   

Selected Publications

Kabos P, Dye WW, Elias A, Horwitz KB, Sartorius CA. Rare ER-/CK5+ cells in luminal type human breast cancers are resistant to hormone therapy and chemotherapy and repopulate ER+ tumors. AACR 100th Annual Meeting 2009, Denver, CO, Abstract # 7489 (oral presentation)

Horwitz KB, Dye WW, Harrell JC, Kabos P, Sartorius CA. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. PNAS. 2008 April 15, 105(15): 5774–5779.

Ehtesham M, Winston JA, Kabos P, Thompson RC. CXCR4 expression mediates glioma cell invasiveness. Oncogene. 2006 May 4;25(19):2801-2806.

Kabos P, Kabosova A, Neuman T. Blocking HES1 expression initiates GABAergic differentiation and induces the expression of p21(CIP1/WAF1) in human neural stem cells. J Biol Chem. 2002 Mar 15;277(11):8763-8766.

Funding

ASCO Young Investigator Award
Breast Cancer Spore Seed Grant